SEC Form 4 · accession 0001437749-26-022661
Nuo Therapeutics, Inc. · AURX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Mintz
Director
Period of report
Jun 29, 2026
Accepted (ET)
Jul 2, 2026 · 8:58 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001091596
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $1.01 | Jun 29, 2026 | A | 30,000 | A | Jun 30, 2027 | Jun 29, 2036 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1The options fully vest as of June 30, 2027.